Harvard researchers engineer proteins

Researchers prove they can engineer proteins to find new targets with high selectivity, a critical advance toward potential new treatments to help neuroregeneration, cytokine storm.

Caitlin McDermott-Murphy • harvard
March 4, 2021 ~7 min

Immune system may keep tabs on the brain from afar

New findings may solve a longstanding mystery about the immune system: How does it know what's going on in the brain? From a distance, researchers say.

Tamara Bhandari-Washington University • futurity
Jan. 29, 2021 ~8 min

Human muscle fights inflammation all by itself

When exercised, human muscle can ward off the damaging effects of chronic inflammation, according to a new study using lab-grown muscle.

Ken Kingery-Duke • futurity
Jan. 25, 2021 ~6 min

They don't come as pills, but try these 6 underprescribed lifestyle medicines for a better, longer life

Lifestyle medicine targets the root of chronic diseases like obesity, heart disease and diabetes. Experts explain why everyone should embrace these free prescriptions for good health.

Michael Parkinson, Senior Medical Director of Health and Productivity, UPMC Health Plan & Workpartners, University of Pittsburgh • conversation
Jan. 20, 2021 ~10 min

Inflammation gives C. diff 2 survival benefits

The inflammation caused by Clostridioides difficile (C. diff) infection gives the pathogen a two-fold advantage that helps it thrive, a new study shows.

Tracey Peake-NC State • futurity
Jan. 19, 2021 ~4 min

Stronger early immune reaction might make COVID worse

While having a robust immune response to coronavirus infection may sound helpful, a new study shows the opposite may be true.

Leslie Tate-Tulane • futurity
Dec. 3, 2020 ~4 min

Vaccines against SARS-CoV-2 will have side effects – that's a good thing

The side effects of new SARS-CoV-2 vaccines are a result of immune system activation. While uncomfortable, they are both normal and expected. They are a sign that the vaccine is working.

Matthew Woodruff, Instructor, Lowance Center for Human Immunology, Emory University • conversation
Dec. 3, 2020 ~9 min

‘Cytokine storms’ aren’t behind most COVID-19 lung failures

Few people with severe COVID-19 suffer from unbridled inflammation, researchers report. That suggests anti-inflammatory drugs may not help most patients.

Tamara Bhandari-Washington University • futurity
Nov. 23, 2020 ~9 min

Cigarette smoke can reprogram cells in your airways, causing COPD to hang on after smoking ends

A new discovery offers hope for ways to treat a debilitating disease that has become a leading cause of death in the US..

Bradley Richmond, Assistant Professor of Medicine, Vanderbilt University • conversation
Oct. 28, 2020 ~8 min

Anti-inflammatory drug improves survival in COVID-19 patients

Researchers have found that a targeted therapy with tocilizumab reduced mortality by 30 percent for critically ill COVID-19 patients when administered within the first two days of ICU admission.

Haley Bridger • harvard
Oct. 20, 2020 ~8 min

/

7